https://www.wyominghealthcareweekly.com/article/904714504-akari-therapeutics-participates-in-virtual-investor-what-this-means-interview-discussing-strategic-partnership-with-wuxi-xdc Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:50:00+00:00 Akari Therapeutics Participates in Virtual Investor “What This Means” Interview Discussing Strategic Partnership with WuXi XDC https://ml.globenewswire.com/media/8d978f50-07a9-40a3-be69-45f51ccd94d9/small/akari-logo-1-jpg.jpg https://www.wyominghealthcareweekly.com/article/904712749-over-60-million-showed-they-are-morethanmyeloma-during-2026-myeloma-action-month Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:45:00+00:00 Over 60 Million Showed They Are #MoreThanMyeloma During 2026 Myeloma Action Month https://ml.globenewswire.com/media/f70068f9-568b-4858-8283-3c96a2db91d6/small/imf-logo-png.png https://www.wyominghealthcareweekly.com/article/904714092-tria-federal-earns-prestigious-2026-usa-today-top-workplaces-award Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:45:00+00:00 Tria Federal Earns Prestigious 2026 USA TODAY Top Workplaces Award https://ml.globenewswire.com/media/c6a30fef-932a-4444-895b-8fa9bb319a80/medium/tria-federal-named-2026-usa-today-top-workplaces-winner.jpeg https://www.wyominghealthcareweekly.com/article/904714152-immix-biopharma-to-participate-in-the-jefferies-global-healthcare-conference Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:45:00+00:00 Immix Biopharma to Participate in the Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/b46d5687-65de-44df-81d5-e36f2665d8e7/small/immix-logonew-gray-png.png https://www.wyominghealthcareweekly.com/article/904712841-highridge-medical-enters-exclusive-distribution-agreement-for-the-waypoint-gps-enabling-technology-platform Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:30:00+00:00 Highridge Medical Enters Exclusive Distribution Agreement for the Waypoint GPS Enabling Technology Platform https://ml.globenewswire.com/media/9ab08b53-05b0-40c5-b314-cc8184345a9b/small/highridge-only-stacked-blk-teal-png.png https://www.wyominghealthcareweekly.com/article/904712907-spectral-ai-to-feature-deepview-system-at-2026-american-burn-association-annual-meeting Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:30:00+00:00 Spectral AI to Feature DeepView® System at 2026 American Burn Association Annual Meeting https://ml.globenewswire.com/media/e51098e6-329d-4efc-acb5-a92a6b8f2a5d/small/spectral-ai-logo-jpg.jpg https://www.wyominghealthcareweekly.com/article/904714550-beech-acres-parenting-center-wins-seven-national-top-workplaces-awards-including-nonprofit-industry-and-culture-excellence-awards Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:30:00+00:00 Beech Acres Parenting Center Wins Seven National Top Workplaces Awards, Including Nonprofit Industry and Culture Excellence Awards https://ml.globenewswire.com/media/2c0100b6-1a0c-4618-b66a-662fd8bd0a98/medium/beech-acres-parenting-center-wins-seven-national-top-workpla.png https://www.wyominghealthcareweekly.com/article/904715021-onconetix-highlights-realbotix-s-launch-of-vinci-ai-vision-system-with-delivery-of-first-vinci-equipped-humanoid-robot-to-ericsson Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:30:00+00:00 Onconetix Highlights Realbotix's Launch of Vinci AI Vision System with Delivery of First Vinci-Equipped Humanoid Robot to Ericsson https://ml.globenewswire.com/media/4824d51d-2ecb-4f49-8b75-fe9b920e7b1c/small/onconetix-logo-jpg.jpg https://www.wyominghealthcareweekly.com/article/904715493-annovis-announces-10-million-underwritten-offering-of-common-stock-and-accompanying-warrants Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:30:00+00:00 Annovis Announces $10 Million Underwritten Offering of Common Stock and Accompanying Warrants https://ml.globenewswire.com/media/7ee459df-d33f-4f42-b27c-3bd20487d50c/small/annovis-corp-image-png.png https://www.wyominghealthcareweekly.com/article/904713032-sparian-biosciences-announces-initiation-of-phase-1-clinical-trial-of-sbs-147-next-generation-arylepoxamide-agonist-for-the-treatment-of-pain-funded Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:12:00+00:00 Sparian Biosciences Announces Initiation of Phase 1 Clinical Trial of SBS-147 Next Generation Arylepoxamide Agonist for the Treatment of Pain Funded by a $15M NIH Grant https://ml.globenewswire.com/media/25f3d2f5-2580-472e-8ab8-7adfdd518e4b/small/sparian-bio-logo-jpg.jpg https://www.wyominghealthcareweekly.com/article/904712132-nkgen-biotech-to-present-troculeucel-mechanism-data-in-alzheimer-s-and-frontotemporal-dementia-at-the-neuroimmunology-drug-development-summit Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:05:00+00:00 NKGen Biotech to Present Troculeucel Mechanism Data in Alzheimer’s and Frontotemporal Dementia at the Neuroimmunology Drug Development Summit https://ml.globenewswire.com/media/756e1bcd-a22f-4971-bf36-2be2aa012814/small/nkgen-biotech-rgb-jpg.jpg https://www.wyominghealthcareweekly.com/article/904711704-boehringer-ingelheim-to-evaluate-innovative-combination-of-dll3-targeting-t-cell-engager-plus-pd-l1-vegf-a-bispecific-antibody-in-small-cell-lung Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:00:00+00:00 Boehringer Ingelheim to evaluate innovative combination of DLL3‑targeting T‑cell engager plus PD‑L1/VEGF‑A bispecific antibody in small cell lung cancer https://ml-eu.globenewswire.com/media/f121dfae-77e7-4a01-b1ef-6b757767ddab/small/111boehringer-ingelheim-logo-rgb-dark-green-002-png.png https://www.wyominghealthcareweekly.com/article/904712066-kestra-medical-technologies-named-a-2026-usa-today-top-workplaces-award-winner Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:00:00+00:00 Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner https://ml.globenewswire.com/media/88c5ad8d-436a-4085-8905-f884861df934/small/kestra-medical-technologies-1200x628-3-jpg.jpg https://www.wyominghealthcareweekly.com/article/904712184-cloudbreak-pharma-announces-launch-of-cloudbreakpharma-com-to-raise-awareness-of-its-pipeline-of-novel-first-in-class-therapeutics-to-treat-serious Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:00:00+00:00 Cloudbreak Pharma Announces Launch of Cloudbreakpharma.com to Raise Awareness of its Pipeline of Novel First-in-Class Therapeutics to Treat Serious Underserved Ophthalmic Diseases https://ml.globenewswire.com/media/a68e17c2-8a7a-44cf-bf9d-22382ad4109d/small/cloudbreak-pharma-logo-file-png.png https://www.wyominghealthcareweekly.com/article/904712226-rhythm-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-tuesday-may-5-2026 Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:00:00+00:00 Rhythm Pharmaceuticals to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026 https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg https://www.wyominghealthcareweekly.com/article/904712230-amneal-launches-bimatoprost-ophthalmic-solution-0-01 Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:00:00+00:00 Amneal Launches Bimatoprost Ophthalmic Solution, 0.01% https://ml.globenewswire.com/media/a20d6f40-90af-422f-ab14-47208fdbad2f/small/amneal-rgb-k-png.png https://www.wyominghealthcareweekly.com/article/904712240-cerevance-to-present-positive-phase-2-solengepras-data-in-parkinson-s-disease-at-the-american-academy-of-neurology-2026-annual-meeting Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:00:00+00:00 Cerevance to Present Positive Phase 2 Solengepras Data in Parkinson’s Disease at the American Academy of Neurology 2026 Annual Meeting https://ml.globenewswire.com/media/7b8bba27-38bb-484c-afef-fc5a539ec4e5/small/cerevance-logo-px-jpg.jpg https://www.wyominghealthcareweekly.com/article/904712301-alignment-healthcare-to-announce-first-quarter-2026-financial-results-and-host-conference-call-thursday-april-30-2026 Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:00:00+00:00 Alignment Healthcare to Announce First Quarter 2026 Financial Results and Host Conference Call Thursday, April 30, 2026 https://ml.globenewswire.com/media/c6122501-032d-4425-bb0d-759ee3d3fe68/small/alignmenthealthcare-primary-logo-verticala-png.png https://www.wyominghealthcareweekly.com/article/904712458-nautilus-biotechnology-to-announce-first-quarter-2026-financial-results-on-april-28-2026 Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:00:00+00:00 Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026 https://ml.globenewswire.com/media/0ba69f20-8571-4745-a3f7-6c595c1b0198/small/nautilus-primary-logo-blue-jpg.jpg https://www.wyominghealthcareweekly.com/article/904712579-bcan-names-ferring-pharmaceuticals-and-the-astellas-pfizer-alliance-as-national-presenting-sponsors-of-the-2026-walks-to-end-bladder-cancer Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:00:00+00:00 BCAN Names Ferring Pharmaceuticals and the Astellas/Pfizer Alliance as National Presenting Sponsors of the 2026 Walks to End Bladder Cancer https://media.muckrack.com/press_releases/wK/images/bcan_full-logo_bcan-full-color-logo_medium-4e079058-d690-422a-a6f6-9d79.png https://www.wyominghealthcareweekly.com/article/904712894-kyverna-therapeutics-to-host-conference-call-on-new-data-across-neuroimmunology-franchise-at-aan-2026 Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:00:00+00:00 Kyverna Therapeutics to Host Conference Call on New Data Across Neuroimmunology Franchise at AAN 2026 https://ml.globenewswire.com/media/c166e9f5-941a-48b0-be17-c24d54785784/small/kyverna-primary-full-2-png.png https://www.wyominghealthcareweekly.com/article/904712900-aim-immunotech-to-participate-in-live-virtual-investor-closing-bell-event Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:00:00+00:00 AIM ImmunoTech to Participate in Live Virtual Investor Closing Bell Event https://ml.globenewswire.com/media/8e85b83b-047f-4f99-9c51-1aa232ffe9bb/small/aimlogo-jpg.jpg https://www.wyominghealthcareweekly.com/article/904712910-assembly-biosciences-highlights-presentations-on-positive-phase-1b-data-for-abi-5366-and-abi-1179-in-recurrent-genital-herpes-at-escmid-global-2026 Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:00:00+00:00 Assembly Biosciences Highlights Presentations on Positive Phase 1b Data for ABI-5366 and ABI-1179 in Recurrent Genital Herpes at ESCMID Global 2026 https://ml.globenewswire.com/media/33089548-b62b-412d-9343-ae38d8b720c6/small/assemblybio-logo-rgb-png.png https://www.wyominghealthcareweekly.com/article/904712962-valitor-to-participate-in-the-25th-annual-needham-virtual-healthcare-conference Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:00:00+00:00 Valitor to Participate in the 25th Annual Needham Virtual Healthcare Conference https://ml.globenewswire.com/media/58da3c80-c616-4358-9bbe-2936ace96649/small/valitor-sidebyside-png.png https://www.wyominghealthcareweekly.com/article/904714115-seer-and-precision-health-research-singapore-sign-collaboration-to-provide-deep-unbiased-proteomics-on-10-000-precise-sg100k-samples Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:00:00+00:00 Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples https://ml.globenewswire.com/media/a5aaadad-13a1-4dbd-8ba2-d57cbbc610fb/small/seer-brandmark-rgb-full-jpg.jpg https://www.wyominghealthcareweekly.com/article/904714155-noom-and-b-well-partner-to-launch-integrated-health-record-access-for-medicare-members Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:00:00+00:00 Noom and b.well Partner to Launch Integrated Health Record Access for Medicare Members https://ml.globenewswire.com/media/346e4543-cd37-4391-86d5-f1b5824cbc4a/small/noom-wordmark-black-png.png https://www.wyominghealthcareweekly.com/article/904715098-zentalis-pharmaceuticals-announces-400mg-qd-5-2-azenosertib-monotherapy-as-the-pivotal-study-dose-in-cyclin-e1-positive-platinum-resistant-ovarian Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:00:00+00:00 Zentalis Pharmaceuticals Announces 400mg QD 5:2 Azenosertib Monotherapy as the Pivotal Study Dose in Cyclin E1-Positive Platinum-Resistant Ovarian Cancer https://ml.globenewswire.com/media/1b481d6d-51c9-44f0-b33f-81feb1061d2e/small/zentalis-logo-png.png https://www.wyominghealthcareweekly.com/article/904715174-curonix-llc-announces-appointment-of-don-payerle-to-its-board-of-managers-strengthening-strategic-leadership Wyoming Healthcare Weekly en PressRelease 2026-04-09T12:00:00+00:00 Curonix LLC Announces Appointment of Don Payerle to its Board of Managers, Strengthening Strategic Leadership https://ml.globenewswire.com/media/6eea76ae-3d4d-421b-886f-9e9da10f08bf/small/curonix-primarylogo-cmyk-png.png https://www.wyominghealthcareweekly.com/article/904712847-nexalin-announces-peer-reviewed-study-showing-the-company-s-difs-technology-reduced-self-injury-and-depression-symptoms-in-female-adolescents Wyoming Healthcare Weekly en PressRelease 2026-04-09T11:47:00+00:00 Nexalin Announces Peer-Reviewed Study Showing the Company’s DIFS™ Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents https://ml.globenewswire.com/media/7f481b55-16b6-4c8a-8356-30d54079a605/small/nexalin-jpg.jpg https://www.wyominghealthcareweekly.com/article/904711871-smith-nephew-s-regeneten-bioinductive-implant-shows-post-operative-recovery-times-halved-and-high-healing-rates-for-partial-thickness-rotator-cuff Wyoming Healthcare Weekly en PressRelease 2026-04-09T11:30:00+00:00 Smith+Nephew’s REGENETEN◊ Bioinductive Implant shows post-operative recovery times halved, and high healing rates for partial-thickness rotator cuff tears1,* https://ml-eu.globenewswire.com/media/8512c693-36e3-49c5-9341-0e33875d614d/small/s-n-logo-jpg.jpg https://www.wyominghealthcareweekly.com/article/904713192-amn-healthcare-to-hold-first-quarter-2026-earnings-conference-call-on-thursday-may-7-2026 Wyoming Healthcare Weekly en PressRelease 2026-04-09T11:30:00+00:00 AMN Healthcare to Hold First Quarter 2026 Earnings Conference Call on Thursday, May 7, 2026 https://ml.globenewswire.com/media/7ac9ce26-e0ee-41e1-94d5-cf8155014873/small/large-amn-logo-wtagline-jpg.jpg https://www.wyominghealthcareweekly.com/article/904714153-kura-oncology-to-present-darlifarnib-plus-cabozantinib-data-in-patients-with-clear-cell-renal-cell-carcinoma-previously-treated-with-cabozantinib-at Wyoming Healthcare Weekly en PressRelease 2026-04-09T11:30:00+00:00 Kura Oncology to Present Darlifarnib Plus Cabozantinib Data in Patients with Clear Cell Renal Cell Carcinoma Previously Treated with Cabozantinib at IKCS Europe 2026 https://ml.globenewswire.com/media/ebf510d7-3727-4cc8-894f-6ce2d82b941a/small/kura-logo-for-globe-newswire-prs-png.png https://www.wyominghealthcareweekly.com/article/904714548-plus-therapeutics-appoints-eric-j-daniels-m-d-mba-as-chief-development-officer-to-advance-clinical-pipeline Wyoming Healthcare Weekly en PressRelease 2026-04-09T11:30:00+00:00 Plus Therapeutics Appoints Eric J. Daniels, M.D., MBA, as Chief Development Officer to Advance Clinical Pipeline https://ml.globenewswire.com/media/92d7aa70-e37d-4870-bccf-d83b68ba5612/small/plus-logo-png.png https://www.wyominghealthcareweekly.com/article/904715067-inflarx-reports-new-mechanistic-data-for-izicopan-supporting-its-potential-as-a-best-in-class-c5ar-inhibitor Wyoming Healthcare Weekly en PressRelease 2026-04-09T11:30:00+00:00 InflaRx Reports New Mechanistic Data for Izicopan Supporting its Potential as a Best-in-Class C5aR Inhibitor https://ml.globenewswire.com/media/e017df5c-9a9b-4f4f-9a94-6c2eeb0400bc/small/inflarx-logo-png.png https://www.wyominghealthcareweekly.com/article/904715401-weight-watchers-announces-board-committee-appointments Wyoming Healthcare Weekly en PressRelease 2026-04-09T11:30:00+00:00 Weight Watchers Announces Board Committee Appointments https://ml.globenewswire.com/media/f435b439-7f75-4d2f-a6cc-0e4e2ed811ea/small/weightwatchers-wordmark-boldblue-png.png https://www.wyominghealthcareweekly.com/article/904713643-invivyd-announces-revolution-program-progress-and-advancement-of-novel-potential-first-and-best-in-class-measles-monoclonal-antibody-candidate Wyoming Healthcare Weekly en PressRelease 2026-04-09T11:01:00+00:00 Invivyd Announces REVOLUTION Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate VMS063 for Treatment and Prevention of Measles https://ml.globenewswire.com/media/7bf12f50-1073-4ce7-81ac-89426c07add3/small/untitled-design-2-png.png https://www.wyominghealthcareweekly.com/article/904711530-indivior-to-report-first-quarter-2026-financial-results-and-host-webcast-on-april-30th Wyoming Healthcare Weekly en PressRelease 2026-04-09T11:00:00+00:00 Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th   https://ml-eu.globenewswire.com/media/42de3285-90ea-4020-a3ad-25f71026b41a/small/indivior-logo-jpg.jpg https://www.wyominghealthcareweekly.com/article/904711837-oxford-biotherapeutics-enters-strategic-collaboration-with-bristol-myers-squibb-to-discover-and-develop-next-generation-t-cell-engagers-for-solid Wyoming Healthcare Weekly en PressRelease 2026-04-09T11:00:00+00:00 Oxford BioTherapeutics Enters Strategic Collaboration with Bristol Myers Squibb to Discover and Develop Next-Generation T-cell Engagers for Solid Tumours https://ml-eu.globenewswire.com/media/739bbec9-903d-4ef2-8782-7f8592fa370b/small/obt-rgb-1417-544-2-jpg.jpg https://www.wyominghealthcareweekly.com/article/904712256-soleo-health-opens-new-ambulatory-infusion-center-in-austin-texas Wyoming Healthcare Weekly en PressRelease 2026-04-09T11:00:00+00:00 Soleo Health Opens New Ambulatory Infusion Center in Austin, Texas https://ml.globenewswire.com/media/b3c4bcdc-fa25-4f50-8b81-09f13e80a008/small/soleo-logo-1024-x-1024-png.png https://www.wyominghealthcareweekly.com/article/904712687-rani-therapeutics-appoints-dr-sara-kenkare-mitra-as-strategic-advisor-to-advance-platform-and-clinical-strategy Wyoming Healthcare Weekly en PressRelease 2026-04-09T11:00:00+00:00 Rani Therapeutics Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategy https://ml.globenewswire.com/media/8ce7774c-3696-4aa1-8bcd-413805f0a642/small/rani-logo-jpg.jpg https://www.wyominghealthcareweekly.com/article/904712896-satellos-to-present-at-the-bloom-burton-co-healthcare-investor-conference Wyoming Healthcare Weekly en PressRelease 2026-04-09T11:00:00+00:00 Satellos to Present at the Bloom Burton & Co. Healthcare Investor Conference https://ml.globenewswire.com/media/3fe5e759-e0bb-4bc7-9979-e58a67f5f684/small/satellos-logo-gradient-black-png.png https://www.wyominghealthcareweekly.com/article/904713189-click-therapeutics-and-boehringer-ingelheim-announce-series-d-investment-and-funding-to-advance-commercialization-of-ct-155 Wyoming Healthcare Weekly en PressRelease 2026-04-09T11:00:00+00:00 Click Therapeutics and Boehringer Ingelheim Announce Series D Investment and Funding to Advance Commercialization of CT-155 https://ml.globenewswire.com/media/a5dbc566-2d0e-4ce1-abfd-6eed36bcff6b/small/logo-main-1-jpg.jpg https://www.wyominghealthcareweekly.com/article/904713399-foghorn-therapeutics-to-present-new-preclinical-data-for-selective-smarca2-inhibitor-fhd-909-and-selective-cbp-ep300-and-arid1b-degrader-programs-at Wyoming Healthcare Weekly en PressRelease 2026-04-09T11:00:00+00:00 Foghorn Therapeutics to Present New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting https://ml.globenewswire.com/media/742c7e36-c026-4cb2-b89a-933512e66fea/small/foghorn-logo-color-jpg.jpg https://www.wyominghealthcareweekly.com/article/904714045-netramark-authored-peer-reviewed-article-suggests-psychedelics-might-not-only-affect-brain-chemistry-they-may-also-involve-quantum-level-processes Wyoming Healthcare Weekly en PressRelease 2026-04-09T11:00:00+00:00 Netramark-Authored, Peer-Reviewed Article Suggests Psychedelics Might Not Only Affect Brain Chemistry, They May Also Involve Quantum-Level Processes Inside the Brain https://ml.globenewswire.com/media/d65cf3f8-cf9c-475c-b740-09a659269da4/small/netramark-word-eye-blk-jpg.jpg https://www.wyominghealthcareweekly.com/article/904714161-kymera-therapeutics-announces-gilead-sciences-option-exercise-to-license-kt-200-oral-cdk2-molecular-glue-degrader-development-candidate Wyoming Healthcare Weekly en PressRelease 2026-04-09T11:00:00+00:00 Kymera Therapeutics Announces Gilead Sciences’ Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate https://ml.globenewswire.com/media/4d3d3283-c57d-401e-9e1b-53f17e22d76b/small/kymera-logo-rgb-denim-marigold-high-res-png.png https://www.wyominghealthcareweekly.com/article/904714516-seres-therapeutics-to-present-at-carb-x-investor-day Wyoming Healthcare Weekly en PressRelease 2026-04-09T11:00:00+00:00 Seres Therapeutics to Present at CARB-X Investor Day https://ml.globenewswire.com/media/f8c3ad50-d1a3-457d-b0c7-8f9237db7f93/small/seres-logo-png.png https://www.wyominghealthcareweekly.com/article/904714552-nkarta-to-participate-in-needham-virtual-healthcare-conference Wyoming Healthcare Weekly en PressRelease 2026-04-09T11:00:00+00:00 Nkarta to Participate in Needham Virtual Healthcare Conference https://ml.globenewswire.com/media/09e7df7f-9555-45c9-bef1-86131c859ed3/small/nkarta-logo-2022-jpg.jpg https://www.wyominghealthcareweekly.com/article/904714670-medicenna-therapeutics-appoints-dr-nageatte-ibrahim-as-chief-medical-officer Wyoming Healthcare Weekly en PressRelease 2026-04-09T11:00:00+00:00 Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim as Chief Medical Officer https://ml.globenewswire.com/media/1644a38b-bed9-4a76-96fa-d57dd028e650/small/medicenna-jpg.jpg https://www.wyominghealthcareweekly.com/article/904712808-c4-therapeutics-expands-long-term-partnership-with-roche-through-new-collaboration-agreement-focused-on-discovering-and-developing-degrader-antibody Wyoming Healthcare Weekly en PressRelease 2026-04-09T10:59:00+00:00 C4 Therapeutics Expands Long-Term Partnership with Roche Through New Collaboration Agreement Focused on Discovering and Developing Degrader-Antibody Conjugates (DACs) https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png https://www.wyominghealthcareweekly.com/article/904694514-zymeworks-announces-additional-leadership-appointments-to-advance-next-phase-of-growth Wyoming Healthcare Weekly en PressRelease 2026-04-09T10:00:00+00:00 Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth https://ml.globenewswire.com/media/de376a45-7a16-49db-8ad4-65ff45472c90/small/zymeworks-logo-color-png.png https://www.wyominghealthcareweekly.com/article/904676107-leads-biolabs-opamtistomig-pd-l1-4-1bb-bispecific-antibody-advances-to-expansion-phase-in-first-line-biliary-tract-cancer-following-positive-safety Wyoming Healthcare Weekly en PressRelease 2026-04-09T08:34:54+00:00 Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Biliary Tract Cancer Following Positive Safety and Preliminary Efficacy Results https://ml.globenewswire.com/media/YzQzYTcyMTMtMGY1ZC00YjllLWFjOGItNTcwZTYwNzgzMDZkLTEzMDgzODktMjAyNi0wNC0wOS1lbg==/tiny/LEADS-BIOLABS-CO-LTD-.png https://www.wyominghealthcareweekly.com/article/904676097-losing-your-voice-millions-experience-persistent-problems-each-year Wyoming Healthcare Weekly en PressRelease 2026-04-09T08:30:00+00:00 Losing Your Voice? Millions Experience Persistent Problems Each Year https://ml.globenewswire.com/media/YTBiMWM5ZmYtZTg5YS00ZTQ2LTk0OWUtNTIxNjc0YmUyMTc4LTUwMDE1NjQ2NC0yMDI2LTA0LTA5LWVu/tiny/American-Speech-Language-Heari.png https://www.wyominghealthcareweekly.com/article/904676087-ecuador-free-of-rabies-project-accelerates-progress-toward-eliminating-dog-mediated-rabies-supported-by-boehringer-ingelheim-s-stop-rabies-program Wyoming Healthcare Weekly en PressRelease 2026-04-09T08:00:00+00:00 Ecuador Free of Rabies project accelerates progress toward eliminating dog-mediated rabies supported by Boehringer Ingelheim’s Stop Rabies program https://ml-eu.globenewswire.com/media/f121dfae-77e7-4a01-b1ef-6b757767ddab/small/111boehringer-ingelheim-logo-rgb-dark-green-002-png.png https://www.wyominghealthcareweekly.com/article/904675982-kainova-therapeutics-expands-phase-i-ii-trial-of-dt-7012-a-treg-depleting-anti-ccr8-antibody-with-first-patient-dosed-in-europe Wyoming Healthcare Weekly en PressRelease 2026-04-09T07:30:00+00:00 Kainova Therapeutics Expands Phase I/II Trial of DT-7012, a Treg-depleting Anti-CCR8 Antibody, with First Patient Dosed in Europe https://ml-eu.globenewswire.com/media/54cf4d5e-d9c2-4e19-bb47-b2001499bc2e/small/kainova-coul-eng-png.png https://www.wyominghealthcareweekly.com/article/904658364-novartis-announces-expansion-of-community-health-programs-to-close-gaps-in-heart-disease-and-cancer-care-targeting-more-than-30-countries-by-2030 Wyoming Healthcare Weekly en PressRelease 2026-04-09T05:15:00+00:00 Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030 https://ml-eu.globenewswire.com/media/f0161a05-9638-4da5-a4af-f9cdb28f0304/small/logo-warm-black-rgb-jpg.jpg https://www.wyominghealthcareweekly.com/article/904658390-basilea-erh-lt-zus-tzliche-usd-6-mio-von-carb-x-f-r-die-klinische-entwicklung-des-antibiotikums-bal2420 Wyoming Healthcare Weekly en PressRelease 2026-04-09T05:15:00+00:00 Basilea erhält zusätzliche USD 6 Mio. von CARB-X für die klinische Entwicklung des Antibiotikums BAL2420 https://ml-eu.globenewswire.com/media/4403c5ae-6c9a-43d2-8c5f-deb2de747a47/small/basilea-logo-jpg.jpg https://www.wyominghealthcareweekly.com/article/904658595-basilea-awarded-additional-carb-x-funding-of-usd-6-million-to-support-the-clinical-development-of-antibiotic-bal2420 Wyoming Healthcare Weekly en PressRelease 2026-04-09T05:15:00+00:00 Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420 https://ml-eu.globenewswire.com/media/4403c5ae-6c9a-43d2-8c5f-deb2de747a47/small/basilea-logo-jpg.jpg https://www.wyominghealthcareweekly.com/article/904642718-new-peer-reviewed-publication-highlights-evidence-of-mother-to-child-transmission-of-lyme-disease-bacteria-during-pregnancy-and-calls-for-urgent Wyoming Healthcare Weekly en PressRelease 2026-04-09T04:00:00+00:00 New Peer-Reviewed Publication Highlights Evidence of Mother-to-Child-Transmission of Lyme Disease Bacteria During Pregnancy and Calls for Urgent Research https://ml.globenewswire.com/media/388871d3-1a1a-48cf-8ebf-c08773485acd/small/bay-area-logo-0425-png.png https://www.wyominghealthcareweekly.com/article/904610880-hutchmed-highlights-data-to-be-presented-at-aacr-annual-meeting-2026 Wyoming Healthcare Weekly en PressRelease 2026-04-09T00:00:00+00:00 HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2026 https://ml.globenewswire.com/media/085957ad-3bec-49ee-b13e-39961b83c7be/small/hutchmed-small-spaced-1000x305-whitebgd-png.png https://www.wyominghealthcareweekly.com/article/904610741-vireo-growth-inc-announces-acquisition-of-the-hawthorne-gardening-company-from-the-scotts-miracle-gro-company Wyoming Healthcare Weekly en PressRelease 2026-04-08T23:45:56+00:00 Vireo Growth Inc. Announces Acquisition of The Hawthorne Gardening Company from The Scotts Miracle-Gro Company https://ml.globenewswire.com/media/d01c0dca-8260-48c8-8ead-e09111cf57b5/small/vireo-horizontalllogolockup-01-png.png https://www.wyominghealthcareweekly.com/article/904595526-nxera-pharma-achieves-second-development-milestone-in-collaboration-with-eli-lilly-targeting-metabolic-diseases Wyoming Healthcare Weekly en PressRelease 2026-04-08T23:33:55+00:00 Nxera Pharma Achieves Second Development Milestone in Collaboration with Eli Lilly Targeting Metabolic Diseases https://ml-eu.globenewswire.com/media/5cc74d52-c86f-4e21-8684-3496281fee15/small/nxera-master-logo-rgb-black-1-png.png https://www.wyominghealthcareweekly.com/article/904595847-telix-strengthens-board-with-additional-director-appointments Wyoming Healthcare Weekly en PressRelease 2026-04-08T22:44:20+00:00 Telix Strengthens Board with Additional Director Appointments https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png https://www.wyominghealthcareweekly.com/article/904595627-capitale-hosts-750-guests-for-the-next-step-s-10-year-gala-raising-500-000-to-support-israel-medical-fund-center Wyoming Healthcare Weekly en PressRelease 2026-04-08T22:04:00+00:00 CAPITALE HOSTS 750 GUESTS FOR THE NEXT STEP’S 10-YEAR GALA, RAISING $500,000 TO SUPPORT ISRAEL MEDICAL FUND CENTER https://i.imgur.com/pOGgotG.jpeg https://www.wyominghealthcareweekly.com/article/904581911-found-health-claims-evaluated-affordable-glp-1-weight-loss-medication-provider-with-free-online-insurance-check Wyoming Healthcare Weekly en PressRelease 2026-04-08T21:25:19+00:00 Found Health Claims Evaluated: Affordable GLP-1 Weight Loss Medication Provider with Free Online Insurance Check https://zingfast.com/wp-content/uploads/2026/04/Found-Health.jpg https://www.wyominghealthcareweekly.com/article/904581705-aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution Wyoming Healthcare Weekly en PressRelease 2026-04-08T21:00:00+00:00 Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution https://ml.globenewswire.com/media/f41706a5-9f61-4772-83f1-6aa50c660788/small/enable-injections-logo-png.png https://www.wyominghealthcareweekly.com/article/904581691-fda-removes-partial-clinical-hold-on-macrogenics-linnet-study Wyoming Healthcare Weekly en PressRelease 2026-04-08T20:30:00+00:00 FDA Removes Partial Clinical Hold on MacroGenics’ LINNET Study https://ml.globenewswire.com/media/72a7b58c-b7ca-4cd5-b2bb-185124351f1c/small/macrogenics-logo-transparent-background-png.png https://www.wyominghealthcareweekly.com/article/904568361-polyrizon-ltd-announces-closing-of-3-5-million-registered-direct-and-private-placements Wyoming Healthcare Weekly en PressRelease 2026-04-08T20:16:00+00:00 Polyrizon Ltd. Announces Closing of $3.5 Million Registered Direct and Private Placements https://ml.globenewswire.com/media/MTZmNTJlZmItOTljMi00Y2I1LThjMTMtMGYwOTZiN2UxN2JiLTUwMDEyOTIyMy0yMDI2LTA0LTA4LWVu/tiny/Polyrizon-Ltd-.png https://www.wyominghealthcareweekly.com/article/904568472-universal-door-meditation-center-hosts-free-public-celebration-of-awakened-zen-master-thich-dieu-thien-s-25-year-milestone-april-11-in-sugar-land Wyoming Healthcare Weekly en PressRelease 2026-04-08T20:15:20+00:00 Universal Door Meditation Center Hosts Free Public Celebration of Awakened Zen Master Thich Dieu Thien's 25-Year Milestone April 11 in Sugar Land, Texas https://ml.globenewswire.com/media/afd79128-3253-46ac-9253-71e6bac13f23/small/udmc-logo-png.png https://www.wyominghealthcareweekly.com/article/904568203-avita-medical-secures-10-year-barda-agreement-worth-up-to-25-5m-to-bolster-u-s-burn-emergency-preparedness Wyoming Healthcare Weekly en PressRelease 2026-04-08T20:10:00+00:00 AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness https://ml.globenewswire.com/media/53ad8139-952a-4470-9ede-2f3bf0521f16/small/avita-png.png https://www.wyominghealthcareweekly.com/article/904567716-immucell-announces-a-28-4-increase-in-product-sales-in-q1-of-2026-based-on-preliminary-unaudited-sales-results Wyoming Healthcare Weekly en PressRelease 2026-04-08T20:05:00+00:00 ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results https://ml.globenewswire.com/media/680330c2-368b-4abc-9429-878b0c9fb1a2/small/immucell-jpg.jpg https://www.wyominghealthcareweekly.com/article/904567720-outset-medical-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Wyoming Healthcare Weekly en PressRelease 2026-04-08T20:05:00+00:00 Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/28778c78-03f1-4b17-9c13-3cc578c924dc/small/outset-id-orangegrey-png.png https://www.wyominghealthcareweekly.com/article/904567722-option-care-health-to-announce-first-quarter-2026-financial-results-and-host-conference-call Wyoming Healthcare Weekly en PressRelease 2026-04-08T20:05:00+00:00 Option Care Health to Announce First Quarter 2026 Financial Results and Host Conference Call https://ml.globenewswire.com/media/OWFhZTIwODktMDI1Ni00ZDcyLWEwMGItMGZmYzc2MWFiZmM0LTEwMTk5NzQtMjAyNi0wNC0wOC1lbg==/tiny/Option-Care-Health-Inc-.png https://www.wyominghealthcareweekly.com/article/904567728-crinetics-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-may-7-2026 Wyoming Healthcare Weekly en PressRelease 2026-04-08T20:05:00+00:00 Crinetics Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026 https://ml.globenewswire.com/media/ff5e7cfa-b9fb-4679-8bf3-6e9d25207b83/small/crinetics-logo-trademark-jpg-1-jpg.jpg https://www.wyominghealthcareweekly.com/article/904567783-clover-health-to-report-first-quarter-2026-financial-results-on-may-6-2026 Wyoming Healthcare Weekly en PressRelease 2026-04-08T20:05:00+00:00 Clover Health to Report First Quarter 2026 Financial Results on May 6, 2026 https://ml.globenewswire.com/media/1a48a25b-b654-4d62-adb3-d1a776346264/small/clover-logo-green-rgb-jpg.jpg https://www.wyominghealthcareweekly.com/article/904567977-rxsight-highlights-300-000-light-adjustable-lens-implant-milestone-and-strong-scientific-presence-at-ascrs-2026 Wyoming Healthcare Weekly en PressRelease 2026-04-08T20:05:00+00:00 RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026 https://ml.globenewswire.com/media/48441335-c938-45ff-9355-ba8e331354e9/small/rxsight-globe-png.png https://www.wyominghealthcareweekly.com/article/904568342-annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference Wyoming Healthcare Weekly en PressRelease 2026-04-08T20:05:00+00:00 Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference https://ml.globenewswire.com/media/fda933a1-e95d-4cae-8894-7b2354118e20/small/annexon-logo-rgb-png.png https://www.wyominghealthcareweekly.com/article/904568377-kyntra-bio-to-present-at-the-25th-annual-needham-virtual-healthcare-conference Wyoming Healthcare Weekly en PressRelease 2026-04-08T20:05:00+00:00 Kyntra Bio to Present at the 25th Annual Needham Virtual Healthcare Conference https://ml.globenewswire.com/media/9105c1e9-d9e3-4b68-9fc8-261fed7db250/small/kyntra-bio-r-rgb-png.png https://www.wyominghealthcareweekly.com/article/904568428-nexgel-reschedules-shareholder-update-conference-call-to-april-15th-at-4-30-p-m-et-to-provide-update-on-celularity-transaction Wyoming Healthcare Weekly en PressRelease 2026-04-08T20:05:00+00:00 NEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity Transaction https://ml.globenewswire.com/media/0e76fff8-7aee-4b60-ba26-62dda9975939/small/logo-png.png https://www.wyominghealthcareweekly.com/article/904567669-inventiva-annonce-le-d-p-t-de-son-document-d-enregistrement-universel-2025-et-de-son-rapport-annuel-2025-form-20-f Wyoming Healthcare Weekly en PressRelease 2026-04-08T20:00:00+00:00 Inventiva annonce le dépôt de son Document d’Enregistrement Universel 2025 et de son Rapport Annuel 2025 (« Form 20-F ») https://ml-eu.globenewswire.com/media/d96e203b-8941-46c7-888a-508900ab9a8b/small/ https://www.wyominghealthcareweekly.com/article/904567678-proqr-highlights-pipeline-expansion-and-multiple-upcoming-clinical-catalysts-at-investor-and-analyst-event Wyoming Healthcare Weekly en PressRelease 2026-04-08T20:00:00+00:00 ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event https://ml-eu.globenewswire.com/media/f5ae7794-bff7-44dc-8709-0e9c3a9eac77/small/logo-proqr-150x150-png.png https://www.wyominghealthcareweekly.com/article/904567684-inventiva-announces-filing-of-its-2025-universal-registration-document-and-2025-annual-report-on-form-20-f Wyoming Healthcare Weekly en PressRelease 2026-04-08T20:00:00+00:00 Inventiva announces filing of its 2025 Universal Registration Document and 2025 Annual Report on Form 20-F https://ml-eu.globenewswire.com/media/d96e203b-8941-46c7-888a-508900ab9a8b/small/logo-iva-jpg.jpg https://www.wyominghealthcareweekly.com/article/904554654-parker-university-women-s-volleyball-wins-2026-ncvf-national-championship Wyoming Healthcare Weekly en PressRelease 2026-04-08T18:44:29+00:00 PARKER UNIVERSITY WOMEN’S VOLLEYBALL WINS 2026 NCVF NATIONAL CHAMPIONSHIP https://ml.globenewswire.com/media/NjBkOWNmMWMtMWQ4NS00NmY4LWFjNDYtODBmZjAzMDhhNTc5LTEyMTMzODItMjAyNi0wNC0wOC1lbg==/tiny/Parker-University.png https://www.wyominghealthcareweekly.com/article/904554686-neura-supplement-claims-evaluated-the-7-second-red-goji-berry-recipe-memory-trick-for-neura-shield-cognitive-performance Wyoming Healthcare Weekly en PressRelease 2026-04-08T18:41:48+00:00 Neura Supplement Claims Evaluated: The 7-Second Red Goji Berry Recipe Memory Trick for Neura Shield Cognitive Performance https://zingfast.com/wp-content/uploads/2026/04/Neura-Supplement.jpg https://www.wyominghealthcareweekly.com/article/904542286-ergodyne-readies-work-crews-for-the-dangers-of-warmer-temps Wyoming Healthcare Weekly en PressRelease 2026-04-08T17:00:00+00:00 Ergodyne Readies Work Crews for the Dangers of Warmer Temps https://ml.globenewswire.com/media/NTgwMTM4MWQtYWIwOS00ZWIwLTlmMzAtYWExM2UyNDk3NTM5LTExODg4MTAtMjAyNi0wNC0wOC1lbg==/tiny/Ergodyne.png https://www.wyominghealthcareweekly.com/article/904542370-ascendis-pharma-to-list-ordinary-shares-directly-on-nasdaq Wyoming Healthcare Weekly en PressRelease 2026-04-08T16:00:00+00:00 Ascendis Pharma to List Ordinary Shares Directly on Nasdaq https://ml.globenewswire.com/media/b4b7c29a-478e-4a8e-b23b-b6a1cb18aee8/small/ascendis-final-logo-7-23-15-png.png https://www.wyominghealthcareweekly.com/article/904529759-trogenix-announces-publication-of-breakthrough-pre-clinical-data-in-nature-demonstrating-complete-tumour-eradication-and-durable-protection-in Wyoming Healthcare Weekly en PressRelease 2026-04-08T15:02:54+00:00 Trogenix announces publication of breakthrough pre-clinical data in Nature demonstrating complete tumour eradication and durable protection in aggressive brain cancer model https://ml-eu.globenewswire.com/media/1df677d2-fb59-4859-a4a8-d74bdb945eca/small/trogenix-rgb-80-jpg.jpg https://www.wyominghealthcareweekly.com/article/904529871-new-23andme-research-institute-study-identifies-genetic-predictors-for-glp-1-weight-loss-efficacy-and-side-effects Wyoming Healthcare Weekly en PressRelease 2026-04-08T15:00:00+00:00 New 23andMe Research Institute Study Identifies Genetic Predictors for GLP-1 Weight Loss Efficacy and Side Effects https://ml.globenewswire.com/media/e614a219-c44d-4fb3-8c94-b3a330509af9/small/23andme-ri-logo-stacked-color-min-png.png https://www.wyominghealthcareweekly.com/article/904530092-booking-health-releases-2026-report-on-advanced-head-and-neck-cancer-treatment-for-international-patients Wyoming Healthcare Weekly en PressRelease 2026-04-08T14:50:00+00:00 Booking Health Releases 2026 Report on Advanced Head and Neck Cancer Treatment for International Patients https://pressranger.s3.us-west-1.amazonaws.com/3226262/1775134246_1024_depositphotos_844658038_xl-1.jpg https://www.wyominghealthcareweekly.com/article/904519657-steadman-philippon-research-institute-and-hospital-for-special-surgery-to-host-vail-hip-summit-april-9-11-at-four-seasons-resort-vail Wyoming Healthcare Weekly en PressRelease 2026-04-08T14:00:05+00:00 Steadman Philippon Research Institute and Hospital for Special Surgery to Host Vail Hip Summit April 9–11 at Four Seasons Resort Vail https://ml.globenewswire.com/media/ZmRlMzIwMzQtOGY1Zi00MjQ0LTljNmYtNzM3ODFmMWM5NTkxLTExMDM2NjEtMjAyNi0wNC0wOC1lbg==/tiny/Steadman-Philippon-Research-In.png https://www.wyominghealthcareweekly.com/article/904519445-root-brands-addresses-the-glp-1-gap-with-crush-and-sculpt-a-science-driven-protocol-for-metabolic-and-muscle-support-after-ozempic-and-wegovy Wyoming Healthcare Weekly en PressRelease 2026-04-08T13:41:42+00:00 ROOT Brands® Addresses the GLP-1 Gap with CRUSH and SCULPT, a Science-Driven Protocol for Metabolic and Muscle Support After Ozempic® and Wegovy® https://ml.globenewswire.com/media/NGE2MTEwYWQtOWMzMy00YWU3LWFmZDMtZjQwNDRmNmI3NzRkLTUwMDE1MDU0NC0yMDI2LTA0LTA4LWVu/tiny/The-ROOT-Brands.png https://www.wyominghealthcareweekly.com/article/904518691-novabridge-reports-full-year-2025-financial-results-and-provides-business-update Wyoming Healthcare Weekly en PressRelease 2026-04-07T20:50:00+00:00 NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update https://ml.globenewswire.com/media/0ea9f005-c7f7-4272-a3ac-cbf4ea4aef15/small/novabridge-logo-en-rgb-png.png https://www.wyominghealthcareweekly.com/article/904364603-vtv-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Wyoming Healthcare Weekly en PressRelease 2026-04-07T20:15:00+00:00 vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/27198d2d-fdd5-4f74-8f54-7a9e5876e06d/small/vtv-therapeutics-color-jpg.jpg https://www.wyominghealthcareweekly.com/article/904364649-voting-rights-and-shares-capital-of-the-company Wyoming Healthcare Weekly en PressRelease 2026-04-07T20:15:00+00:00 Voting Rights and Shares Capital of the Company https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg https://www.wyominghealthcareweekly.com/article/904364730-information-mensuelle-relative-au-nombre-total-de-droits-de-vote-et-d-actions-composant-le-capital-social Wyoming Healthcare Weekly en PressRelease 2026-04-07T20:15:00+00:00 Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg https://www.wyominghealthcareweekly.com/article/904364771-avita-medical-showcases-acute-burn-and-wound-care-portfolio-at-aba-2026-featuring-new-cohealyx-data Wyoming Healthcare Weekly en PressRelease 2026-04-07T20:10:00+00:00 AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data https://ml.globenewswire.com/media/53ad8139-952a-4470-9ede-2f3bf0521f16/small/avita-png.png https://www.wyominghealthcareweekly.com/article/904364829-as-easter-travel-triggers-bed-bug-infestation-warning-fantastic-pest-control-rolls-out-faster-more-efficient-low-pesticide-heat-treatment Wyoming Healthcare Weekly en PressRelease 2026-04-07T20:06:00+00:00 As Easter Travel Triggers Bed Bug Infestation Warning Fantastic Pest Control Rolls Out Faster, More Efficient, Low-pesticide Heat Treatment https://pressranger.s3.us-west-1.amazonaws.com/3226340/65c749bddbdcebd94903357da3d456ca_44_file.jpg https://www.wyominghealthcareweekly.com/article/904364502-brightspring-health-services-inc-to-announce-first-quarter-2026-financial-results-on-may-1-2026 Wyoming Healthcare Weekly en PressRelease 2026-04-07T20:05:00+00:00 BrightSpring Health Services, Inc. to Announce First Quarter 2026 Financial Results on May 1, 2026 https://ml.globenewswire.com/media/db25f94c-83a2-46ba-8d53-c9a0768a71bd/small/brightspring-healthservices-jpg.jpg https://www.wyominghealthcareweekly.com/article/904364525-vaxcyte-to-present-at-the-25th-annual-needham-virtual-healthcare-conference Wyoming Healthcare Weekly en PressRelease 2026-04-07T20:05:00+00:00 Vaxcyte to Present at the 25th Annual Needham Virtual Healthcare Conference https://ml.globenewswire.com/media/7c0fe2be-057f-4a85-b783-cb22e2d6f94d/small/new-logo-with-tagline-jpg.jpg https://www.wyominghealthcareweekly.com/article/904364745-iridex-announces-new-partnership-with-eyeprogpo-to-expand-member-access-to-retina-laser-technology Wyoming Healthcare Weekly en PressRelease 2026-04-07T20:05:00+00:00 Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology https://ml.globenewswire.com/media/2bb80159-a920-428b-aa69-c2f32e3038c9/small/iridex-corporate-logo-horizontal-rgb-m02-jpg.jpg https://www.wyominghealthcareweekly.com/article/904364770-madrigal-pharmaceuticals-announces-grants-of-inducement-awards-under-nasdaq-listing-rule-5635-c-4 Wyoming Healthcare Weekly en PressRelease 2026-04-07T20:05:00+00:00 Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/8fec8de1-1a2e-4f6c-a679-fc43002276ba/small/madrigal-logo-jpg.jpg https://www.wyominghealthcareweekly.com/article/904364836-amneal-to-report-first-quarter-2026-results-on-may-1-2026 Wyoming Healthcare Weekly en PressRelease 2026-04-07T20:01:00+00:00 Amneal to Report First Quarter 2026 Results on May 1, 2026 https://ml.globenewswire.com/media/a20d6f40-90af-422f-ab14-47208fdbad2f/small/amneal-rgb-k-png.png https://www.wyominghealthcareweekly.com/article/904354949-lemaitre-to-present-at-the-25th-annual-needham-virtual-healthcare-conference Wyoming Healthcare Weekly en PressRelease 2026-04-07T18:39:10+00:00 LeMaitre to Present at the 25th Annual Needham Virtual Healthcare Conference https://ml.globenewswire.com/media/8b8755b7-6f04-4650-9c94-0a2d0654fd49/small/lemaitre-2color-rgb-jpg.jpg https://www.wyominghealthcareweekly.com/article/904345601-mhm-invests-237-5-million-to-create-a-healthier-future-across-south-texas Wyoming Healthcare Weekly en PressRelease 2026-04-07T17:47:05+00:00 MHM Invests $237.5 Million to Create a Healthier Future Across South Texas https://ml.globenewswire.com/media/MjM4YmQ3ZDgtN2QzYy00MjdjLTk2ODQtNDllZjc1MjY2N2FiLTEyOTc4OTgtMjAyNi0wNC0wNy1lbg==/tiny/Methodist-Healthcare-Ministrie.png https://www.wyominghealthcareweekly.com/article/904345599-global-dna-read-write-and-edit-market-to-surge-to-67-7-billion-by-2030-driven-by-crispr-advances-genomic-diagnostics-and-expanding-clinical Wyoming Healthcare Weekly en PressRelease 2026-04-07T17:44:41+00:00 Global DNA Read, Write and Edit Market to Surge to $67.7 Billion by 2030, Driven by CRISPR Advances, Genomic Diagnostics and Expanding Clinical Applications https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://www.wyominghealthcareweekly.com/article/904345591-gluco-zen-drops-under-investigation-safety-concerns-arise-amid-researching-the-ingredients-side-effects-risk-for-glucozen Wyoming Healthcare Weekly en PressRelease 2026-04-07T17:35:22+00:00 Gluco Zen Drops Under Investigation: Safety Concerns Arise Amid Researching the Ingredients' Side Effects Risk for GlucoZen https://zingfast.com/wp-content/uploads/2026/04/Gluco-Zen-Drops.jpg https://www.wyominghealthcareweekly.com/article/904345226-genfit-announces-publication-of-the-2025-universal-registration-document Wyoming Healthcare Weekly en PressRelease 2026-04-07T17:30:00+00:00 GENFIT Announces Publication of the 2025 Universal Registration Document   https://ml-eu.globenewswire.com/media/YjA0MjRlZDQtMzQxZS00MDdhLTg3ZGEtZmVhOTQ4ZDQzZWI3LTEwMTEyNjgtMjAyNi0wNC0wNy1lbg==/tiny/GENFIT-S-A-.png https://www.wyominghealthcareweekly.com/article/904345280-genfit-mise-disposition-du-document-d-enregistrement-universel-2025 Wyoming Healthcare Weekly en PressRelease 2026-04-07T17:30:00+00:00 GENFIT : Mise à disposition du Document d’Enregistrement Universel 2025   https://ml-eu.globenewswire.com/media/YjA0MjRlZDQtMzQxZS00MDdhLTg3ZGEtZmVhOTQ4ZDQzZWI3LTEwMTEyNjgtMjAyNi0wNC0wNy1mcg==/tiny/GENFIT-S-A-.png https://www.wyominghealthcareweekly.com/article/904345559-natural-remedies-awarded-american-botanical-council-s-2026-varro-e-tyler-commercial-investment-in-phytomedicinal-research-award Wyoming Healthcare Weekly en PressRelease 2026-04-07T17:19:41+00:00 Natural Remedies Awarded American Botanical Council’s 2026 Varro E. Tyler Commercial Investment in Phytomedicinal Research Award https://ml.globenewswire.com/media/afb640f0-73d1-4cd2-bcbe-9a80b381d7cc/medium/2026-abc-varro-e-tyler-commercial-investment-in-phytomedicin.jpg https://www.wyominghealthcareweekly.com/article/904336536-coeptis-announces-approval-of-z-squared-inc-s-nasdaq-listing-application Wyoming Healthcare Weekly en PressRelease 2026-04-07T16:05:56+00:00 Coeptis Announces Approval of Z Squared Inc.’s Nasdaq Listing Application https://ml.globenewswire.com/media/6ef667b8-3767-4031-9180-f4ba33c81938/small/coeptis-logo-final-rgb-300dpi-png.png https://www.wyominghealthcareweekly.com/article/904327021-heartfocus-and-inteleos-launch-first-ai-cardiac-pocus-certification Wyoming Healthcare Weekly en PressRelease 2026-04-07T15:24:18+00:00 HeartFocus and Inteleos Launch First AI Cardiac POCUS Certification https://ml.globenewswire.com/media/NTFkODg1MzItY2Q4MC00MTY2LTk4NjItODc1OTc1OTA4YjUyLTEyNDUwMzItMjAyNi0wNC0wNy1lbg==/tiny/Inteleos-Inc-.png https://www.wyominghealthcareweekly.com/article/904326952-3-ways-pharmacists-can-help-maximize-your-glp-1-experience Wyoming Healthcare Weekly en PressRelease 2026-04-07T15:01:15+00:00 3 Ways Pharmacists Can Help Maximize Your GLP-1 Experience https://ml.globenewswire.com/Resource/Download/f72143cc-6829-468e-aeb9-94a8dbdcb874/17866-1.jpg https://www.wyominghealthcareweekly.com/article/904318679-speke-ai-to-showcase-ambient-ai-solutions-at-uca-s-2026-urgent-care-convention Wyoming Healthcare Weekly en PressRelease 2026-04-07T14:37:17+00:00 Speke AI to Showcase Ambient AI Solutions at UCA’s 2026 Urgent Care Convention https://ml.globenewswire.com/media/NTE3ZDRhZjgtMjgwNi00MGNkLThlOGItYmQwNzU4OTBiMDNkLTUwMDE1NDA4MS0yMDI2LTA0LTA3LWVu/tiny/Speke-AI.png https://www.wyominghealthcareweekly.com/article/904318654-nextel-medical-corp-announces-pivotal-milestone-in-commercial-launch-of-patent-protected-nanog-dna-cancer-screening-test Wyoming Healthcare Weekly en PressRelease 2026-04-07T14:30:00+00:00 NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test https://ml.globenewswire.com/media/ZmQ2OTkwNDMtN2QzOS00OWQ1LThhYzctYzg5MzFjMjgwODMwLTUwMDE1ODM1Mi0yMDI2LTA0LTA3LWVu/tiny/Exousia-Pro-Inc-.png https://www.wyominghealthcareweekly.com/article/904318466-bioora-and-octane-biotech-sign-letter-of-intent-to-expand-cell-therapy-manufacturing-using-the-cocoon-platform Wyoming Healthcare Weekly en PressRelease 2026-04-07T14:15:00+00:00 BioOra and Octane Biotech Sign Letter of Intent to Expand Cell Therapy Manufacturing Using the Cocoon® Platform https://ml.globenewswire.com/media/YzFhYmQ1NzYtNzA3My00Y2JiLWE2MGQtMjM3ZDBmYzMxNTJhLTEzMDQwMTAtMjAyNi0wNC0wNy1lbg==/tiny/Octane-Medical-Group.png https://www.wyominghealthcareweekly.com/article/904318295-regional-health-properties-reports-fourth-quarter-2025-results Wyoming Healthcare Weekly en PressRelease 2026-04-07T14:05:00+00:00 Regional Health Properties Reports Fourth Quarter 2025 Results https://ml.globenewswire.com/media/bfd51062-4a60-4cf0-9f2f-a4b109b52e4a/small/logo-jpg.jpg https://www.wyominghealthcareweekly.com/article/904318008-folia-health-launches-app-based-study-to-unlock-novel-real-world-evidence-of-symptom-burden-and-unmet-need-for-patients-and-caregivers-in-cidp Wyoming Healthcare Weekly en PressRelease 2026-04-07T14:00:00+00:00 Folia Health Launches App-Based Study to Unlock Novel Real-World Evidence of Symptom Burden and Unmet Need for Patients and Caregivers in CIDP https://ml.globenewswire.com/media/858e11f4-96a0-4321-93eb-d278df849ccf/small/untitled-design-1-png.png https://www.wyominghealthcareweekly.com/article/904318126-inc-recognizes-u-s-oral-surgery-management-for-growth Wyoming Healthcare Weekly en PressRelease 2026-04-07T13:41:00+00:00 Inc. Recognizes U.S. Oral Surgery Management for Growth https://ml.globenewswire.com/media/9472c27c-8b6d-4c87-95fd-31f1f0140263/small/usosm-logo-png.png